The role of fecal calprotectin in pediatric disease

다국어 초록 (Multilingual Abstract)

Fecal calprotectin (FC) is a calcium- and zinc-binding protein of the S100 family, mainly expressed by neutrophils and released during inflammation. FC became an increasingly useful tool both for gastroenterologists and for general practitioners for distinguishing inflammatory bowel disease (IBD) from irritable bowel syndrome. Increasing evidences support the use of this biomarker for diagnosis, follow-up and evaluation of response to therapy of several pediatric gastrointestinal diseases, ranging from IBD to nonspecific colitis and necrotizing enterocolitis. This article summarizes the current literature on the use of FC in clinical practice.

참고문헌 (Reference)

1 Rosso C, "Usefulness of fecal calprotectin determination in pediatric intestinal diseases" 68 : 478-486, 2016

2 Tibble JA, "Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease" 123 : 450-460, 2002

3 Selimoğlu MA, "The role of fecal calprotectin and lactoferrin in the diagnosis of necrotizing enterocolitis" 13 : 452-454, 2012

4 Montalto M, "Role of fecal calprotectin in gastrointestinal disorders" 17 : 1569-1582, 2013

5 Costa F, "Role of faecal calprotectin as non-invasive marker of intestinal inflammation" 35 : 642-647, 2003

6 Kosiewicz MM, "Relationship between gut microbiota and development of T cell associated disease" 588 : 4195-4206, 2014

7 Poullis A, "Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity" 15 : 573-574, 2003

8 Thuijls G, "Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis" 251 : 1174-1180, 2010

9 Fagerhol MK, "Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein?" 49 : M74-9, 1996

10 Wildt S, "Metabolic and inflammatory faecal markers in collagenous colitis" 19 : 567-574, 2007

11 Rugtveit J, "Increased macrophage subset in inflammatory bowel disease : apparent recruitment from peripheral blood monocytes" 35 : 669-674, 1994

12 Tøn H, "Improved assay for fecal calprotectin" 292 : 41-54, 2000

13 Macdonald TT, "Immunity, inflammation, and allergy in the gut" 307 : 1920-1925, 2005

14 Orivuori L, "High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6" 45 : 928-939, 2015

15 Johne B, "Functional and clinical aspects of the myelomonocyte protein calprotectin" 50 : 113-123, 1997

16 Joo Young Song, "Fecal calprotectin level in healthy children aged less than 4 years in South Korea" Wiley 31 (31): e22113-, 2017

17 Caviglia GP, "Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders" 49 : 1419-1424, 2014

18 D'Haens G, "Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease" 18 : 2218-2224, 2012

19 Kallel L, "Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon : a prospective study" 22 : 340-345, 2010

20 Oord T, "Fecal calprotectin in healthy children" 74 : 254-258, 2014

21 Licata A, "Fecal calprotectin in clinical practice : a noninvasive screening tool for patients with chronic diarrhea" 46 : 504-508, 2012

22 Stoll ML, "Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis" 38 : 2274-2275, 2011

23 윤정민, "Fecal calprotectin concentration in neonatal necrotizing enterocolitis" 대한소아청소년과학회 57 (57): 351-356, 2014

24 Chen CC, "Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children" 55 : 541-547, 2012

25 Kant P, "Faecal calprotectin levels before and after weight loss in obese and overweight subjects" 37 : 317-319, 2013

26 Sipponen T, "Faecal calprotectin in children with clinically quiescent inflammatory bowel disease" 45 : 872-877, 2010

27 Mendall MA, "Faecal calprotectin : factors affecting levels and its potential role as a surrogate marker for risk of development of Crohn's Disease" 16 : 126-, 2016

28 Sýkora J, "Evaluation of faecal calprotectin as a valuable non-invasive marker in distinguishing gut pathogens in young children with acute gastroenteritis" 99 : 1389-1395, 2010

29 Poullis A, "Emerging role of calprotectin in gastroenterology" 18 : 756-762, 2003

30 Seo SC, "Elevated fecal calprotectin levels are associated with severity of atopic dermatitis in children" 36 : 82-87, 2018

31 von Roon AC, "Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy" 102 : 803-813, 2007

32 Widlak MM, "Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients" 45 : 354-363, 2017

33 Lee YM, "Delivery and feeding mode affects fecal calprotectin levels in infants <7months old" 108 : 45-48, 2017

34 Sipponen T, "Crohn's disease activity assessed by fecal calprotectin and lactoferrin : correlation with Crohn's disease activity index and endoscopic findings" 14 : 40-46, 2008

35 Actis GC, "Commonalities and differences between Crohn's disease and ulcerative colitis : the genetic clues to their interpretation" 10 : 447-454, 2011

36 Fagerberg UL, "Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms" 40 : 450-455, 2005

37 Stríz I, "Calprotectin-a pleiotropic molecule in acute and chronic inflammation" 53 : 245-253, 2004

38 Nisapakultorn K, "Calprotectin expression inhibits bacterial binding to mucosal epithelial cells" 69 : 3692-3696, 2001

39 Røseth AG, "Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study" 27 : 793-798, 1992

40 Steinbakk M, "Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin" 336 : 763-765, 1990